Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-03 · accession 0001415889-24-000609 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-03 | KNSA | Ragosa Mark | CFO | M - OptEx | $8.83 | +12.0K | 27.6K | +77% | +$106.0K |
| D | 2024-01-04 | 2024-01-03 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $20.00 | -12.0K | 15.6K | -43% | -$240.0K |
| D | 2024-01-04 | 2024-01-03 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-01-03 | M | A | 12,000 | $8.83 | 27,632 | D | — | — | |
| 2 | Common | Class A Common Share | 2024-01-03 | S | D | 12,000 | $20.00 | 15,632 | D | — | — | |
| 3 | Derivative | Share Option | 2024-01-03 | M | D | 12,000 | $0.00 | 0 | D | $8.83 · — to 2029-09-16 | 12,000 Class A Common Share | (F2) This option is fully vested and exercisable. |